Baskings Australia PTY LTD
Suite 1/191 Musgrave Rd, Red Hill QLD 4059, Australia
Clinical trials are an important part of medical research designed to better understand a disease and how new medicines may help health conditions.
Baskings Australia completed a Phase 1 single escalating dose study of BB-031 in Q3 2022. A Phase 2 study in ischemic stroke patients will be initiated in Australia in 2023.
For more information, please contact rjshea@baskingbiosciences.com.au
Partners
